These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 30202773

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Rescue of severe infantile hypophosphatasia mice by AAV-mediated sustained expression of soluble alkaline phosphatase.
    Matsumoto T, Miyake K, Yamamoto S, Orimo H, Miyake N, Odagaki Y, Adachi K, Iijima O, Narisawa S, Millán JL, Fukunaga Y, Shimada T.
    Hum Gene Ther; 2011 Nov; 22(11):1355-64. PubMed ID: 21388343
    [Abstract] [Full Text] [Related]

  • 4. High-Level Expression of Alkaline Phosphatase by Adeno-Associated Virus Vector Ameliorates Pathological Bone Structure in a Hypophosphatasia Mouse Model.
    Nakamura-Takahashi A, Tanase T, Matsunaga S, Shintani S, Abe S, Nitahara-Kasahara Y, Watanabe A, Hirai Y, Okada T, Yamaguchi A, Kasahara M.
    Calcif Tissue Int; 2020 Jun; 106(6):665-677. PubMed ID: 32076747
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Successful gene therapy in utero for lethal murine hypophosphatasia.
    Sugano H, Matsumoto T, Miyake K, Watanabe A, Iijima O, Migita M, Narisawa S, Millán JL, Fukunaga Y, Shimada T.
    Hum Gene Ther; 2012 Apr; 23(4):399-406. PubMed ID: 22133046
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Enzyme replacement therapy prevents dental defects in a model of hypophosphatasia.
    McKee MD, Nakano Y, Masica DL, Gray JJ, Lemire I, Heft R, Whyte MP, Crine P, Millán JL.
    J Dent Res; 2011 Apr; 90(4):470-6. PubMed ID: 21212313
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gene therapy improves dental manifestations in hypophosphatasia model mice.
    Okawa R, Iijima O, Kishino M, Okawa H, Toyosawa S, Sugano-Tajima H, Shimada T, Okada T, Ozono K, Ooshima T, Nakano K.
    J Periodontal Res; 2017 Jun; 52(3):471-478. PubMed ID: 27561677
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice.
    Anderson HC, Harmey D, Camacho NP, Garimella R, Sipe JB, Tague S, Bi X, Johnson K, Terkeltaub R, Millán JL.
    Am J Pathol; 2005 Jun; 166(6):1711-20. PubMed ID: 15920156
    [Abstract] [Full Text] [Related]

  • 17. Dental effects of enzyme replacement therapy in case of childhood-type hypophosphatasia.
    Okawa R, Kokomoto K, Nakano K.
    BMC Oral Health; 2021 Jun 27; 21(1):323. PubMed ID: 34176466
    [Abstract] [Full Text] [Related]

  • 18. Monoclonal antibodies against tissue-nonspecific alkaline phosphatase. Report of the ISOBM TD9 workshop.
    Magnusson P, Arlestig L, Paus E, Di Mauro S, Testa MP, Stigbrand T, Farley JR, Nustad K, Millán JL.
    Tumour Biol; 2002 Jun 27; 23(4):228-48. PubMed ID: 12499779
    [Abstract] [Full Text] [Related]

  • 19. Prenatal enzyme replacement therapy for Akp2 -/- mice with lethal hypophosphatasia.
    Hasegawa A, Nakamura-Takahashi A, Kasahara M, Saso N, Narisawa S, Millán JL, Samura O, Sago H, Okamoto A, Umezawa A.
    Regen Ther; 2021 Dec 27; 18():168-175. PubMed ID: 34277899
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.